Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
OwnerPieter De Haaninventor
Life of this patent
Estimating the term…
Abstract
An immediate-release pharmaceutical dosage form comprising, as the active substance, polymorphous tibolone and pharmaceutically acceptable excipients, wherein the polymorphous tibolone has a mean particle size as defined in the specification of below 22.8 μm in the dosage form.
Claims12
1-7. (canceled)
A pharmaceutical formulation comprising, as the active substance, polymorphous tibolone and pharmaceutically acceptable excipients, wherein the polymorphous tibolone in the pharmaceutical formulation has a mean particle size below 22.8 μm.
A method for the treatment of menopausal complaints comprising administering to a patient in need thereof a pharmaceutically effective amount of a pharmaceutical formulation comprising polymorphous tibolone and pharmaceutically acceptable excipients wherein the polymorphous tibolone in the pharmaceutical formulation has a mean particle size below 22.8 μm.
Dependencies are inferred from the claim text.